SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-035265
Filing Date
2023-12-22
Accepted
2023-12-22 17:09:11
Documents
13
Period of Report
2023-12-20
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K athx20231222_8k.htm   iXBRL 8-K 27859
  Complete submission text file 0001437749-23-035265.txt   149319

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA athx-20231220.xsd EX-101.SCH 3410
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE athx-20231220_def.xml EX-101.DEF 10354
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE athx-20231220_lab.xml EX-101.LAB 13837
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE athx-20231220_pre.xml EX-101.PRE 10349
7 EXTRACTED XBRL INSTANCE DOCUMENT athx20231222_8k_htm.xml XML 2316
Mailing Address 3201 CARNEGIE AVENUE CLEVELAND OH 44115-2634
Business Address 3201 CARNEGIE AVENUE CLEVELAND OH 44115-2634 216-431-9900
ATHERSYS, INC / NEW (Filer) CIK: 0001368148 (see all company filings)

IRS No.: 204864095 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33876 | Film No.: 231510708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)